OmniAb (OABI) Metrics: History & Chart

OmniAb, Inc.(OABI)

Biotechnology · EmeryVille, CA

$4.41-0.51 (-10.47%)

Delayed quote: Oct 6, 2026, 1:20 PM EDT

About OmniAb, Inc.

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

EmeryVille, CA

89 employees

www.omniab.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Matthew W. Foehr

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+3.80%
30D Total Return	+13.63%
YTD Total Return	+165.95%
1Y Total Return	+201.84%
3Y Total Return	-3.91%
5Y Total Return	-50.64%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+165.95%
2025	-47.74%
2024	-42.63%
2023	+71.39%
2022	-64.00%
2021	N/A

CAGR TTM	+200.25%
CAGR 3Y	-1.32%
CAGR 5Y	-13.17%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

OABI Valuation Metrics

OABI Stock Price Metrics

OABI Dividend Metrics

OABI Growth Rate Metrics

OABI Discounted Cash Flow Metrics

OABI Returns By Period

OABI Yearly Returns

OABI Average Annual Returns By Period (CAGR)

OABI Revenue Metrics

OABI PE Ratio Metrics

OABI PS Ratio Metrics

OABI PB Ratio Metrics

OABI Price to Free Cash Flow Ratio Metrics

OABI Debt to Equity Ratio Metrics

OABI PEG Ratio Metrics

OABI FCF Yield

OABI Earnings Yield

OABI EBITDA Yield

OABI OCF Yield

OABI EV/EBIT Ratio Metrics

OABI EV/EBITDA Ratio Metrics

OABI EV/Assets Ratio Metrics

OABI EV/Sales Ratio Metrics

OABI Current Ratio Metrics

OABI Quick Ratio Metrics

OABI ROIC Metrics

OABI Return on Assets Metrics

OABI Return on Equity Metrics

OABI Net Profit Margin Metrics

OABI Gross Profit Margin Metrics

OABI Tax Rate Metrics

PS Ratio	16.49
PS Ratio Avg TTM	10.07
PS Ratio Avg 3Y	12.29
Current VS TTM Avg	+63.71%
Current VS 3Y Avg	+34.22%
Current VS 5Y Avg	+3.50%

PB Ratio	2.43
PB Ratio Avg TTM	0.87
PB Ratio Avg 3Y	1.19
Current VS TTM Avg	+178.87%
Current VS 3Y Avg	+103.79%
Current VS 5Y Avg	+88.92%

PFCF Ratio	651.12
PFCF Ratio Avg TTM	697.87
PFCF Ratio Avg 3Y	766.31
Current VS TTM Avg	-6.70%
Current VS 3Y Avg	-15.03%
Current VS 5Y Avg	-15.03%

Debt/Equity Ratio	0.07
Debt/Equity Ratio Avg TTM	0.08
Debt/Equity Ratio Avg 3Y	0.08
Current VS TTM Avg	-5.08%
Current VS 3Y Avg	-8.64%
Current VS 5Y Avg	-8.05%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.15%
FCF Yield Avg TTM	0.14%
FCF Yield Avg 3Y	0.13%
Current VS TTM Avg	+4.80%
Current VS 3Y Avg	+15.38%
Current VS 5Y Avg	+15.38%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	2.16
Ev/Assets Ratio Avg TTM	0.76
Ev/Assets Ratio Avg 3Y	1.03
Current VS TTM Avg	+185.31%
Current VS 3Y Avg	+109.22%
Current VS 5Y Avg	+81.84%

Ev/Sales Ratio	16.35
Ev/Sales Ratio Avg TTM	9.85
Ev/Sales Ratio Avg 3Y	12.28
Current VS TTM Avg	+66.07%
Current VS 3Y Avg	+33.16%
Current VS 5Y Avg	+2.12%

Current Ratio	4.80
Current Ratio Avg TTM	4.48
Current Ratio Avg 3Y	4.50
Current VS TTM Avg	+7.18%
Current VS 3Y Avg	+6.61%
Current VS 5Y Avg	+41.43%

Quick Ratio	4.80
Quick Ratio Avg TTM	4.47
Quick Ratio Avg 3Y	4.50
Current VS TTM Avg	+7.34%
Current VS 3Y Avg	+6.67%
Current VS 5Y Avg	+41.50%

ROIC	(17.48%)
ROIC Avg 3Y	(23.02%)
ROIC Avg 5Y	(16.99%)
Current VS 3Y Avg	+24.06%
Current VS 5Y Avg	-2.91%
Current VS 10Y Avg	-2.91%

ROA	(15.25%)
ROA Avg TTM	(4.01%)
ROA Avg 3Y	(4.29%)
Current VS TTM Avg	-280.15%
Current VS 3Y Avg	-255.47%
Current VS 5Y Avg	-300.51%

ROE	(17.01%)
ROE Avg TTM	(21.82%)
ROE Avg 3Y	(20.18%)
Current VS TTM Avg	+22.06%
Current VS 3Y Avg	+15.73%
Current VS 5Y Avg	-5.00%

Net Profit Margin	(115.18%)
Net Profit Margin Avg TTM	(282.37%)
Net Profit Margin Avg 3Y	(294.77%)
Current VS TTM Avg	+59.21%
Current VS 3Y Avg	+60.93%
Current VS 5Y Avg	+39.40%

Gross Profit Margin	(18.17%)
Gross Pft Margin Avg TTM	29.15%
Gross Pft Margin Avg 3Y	74.71%
Current VS TTM Avg	-162.34%
Current VS 3Y Avg	-124.32%
Current VS 5Y Avg	-124.70%

Tax Rate	29.23%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A